Compugen (CGEN) EPS (Basic) (2009 - 2026)
Compugen recorded quarterly EPS (Basic) of -$0.08 in Q1 2026, little changed quarter-over-quarter from -$0.08 in Q1 2025, and little changed year-over-year from -$0.08 in Q1 2025.
Compugen's EPS (Basic) history runs 2 years deep, the most recent figure standing at -$0.08 for Q1 2026.
- In Q1 2026, EPS (Basic) changed 0.0% year-over-year to -$0.08; the TTM figure through Mar 2026 stood at -$0.16 (down 100.0% YoY), while the FY2013 annual figure was -$0.36, up 5.26% from the prior year.
- EPS (Basic) came in at -$0.08 for Q1 2026 at Compugen, roughly flat from -$0.08 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.08 in Q1 2025 to a low of -$0.08 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.06 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 4.06 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 6.99 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.55 |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 | -0.08 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.08 |
| Dec 31, 2025 | 0.61 |
| Sep 30, 2025 | -0.07 |
| Jun 30, 2025 | -135,087.50 |
| Mar 31, 2025 | -0.08 |
| Dec 31, 2024 | -0.07 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | -166,230.00 |
| Mar 31, 2024 | -0.08 |
| Dec 31, 2023 | 0.11 |
| Sep 30, 2023 | -0.11 |
| Jun 30, 2023 | -133,333.33 |
| Mar 31, 2023 | -0.11 |
| Dec 31, 2022 | -0.04 |
| Sep 30, 2022 | -0.14 |
| Jun 30, 2022 | 129,836.36 |
| Mar 31, 2022 | -0.11 |
| Dec 31, 2021 | -0.10 |
| Sep 30, 2021 | -0.07 |
| Jun 30, 2021 | -0.11 |
| Mar 31, 2021 | -0.12 |
| Dec 31, 2020 | -0.10 |
| Sep 30, 2020 | -0.09 |
| Jun 30, 2020 | -0.08 |
| Mar 31, 2020 | -0.10 |
| Dec 31, 2019 | -0.10 |
| Sep 30, 2019 | -0.10 |
| Jun 30, 2019 | -0.10 |
| Mar 31, 2019 | -0.14 |
| Dec 31, 2018 | -0.16 |
| Sep 30, 2018 | -0.05 |
| Jun 30, 2018 | -53,647.37 |
| Dec 31, 2017 | -0.18 |
| Sep 30, 2017 | -0.19 |
| Jun 30, 2017 | -26,448.57 |
| Mar 31, 2017 | -0.17 |
| Dec 31, 2016 | -0.17 |
| Sep 30, 2016 | -0.15 |
| Jun 30, 2016 | -0.13 |
| Mar 31, 2016 | -0.17 |
| Dec 31, 2015 | -0.01 |
| Sep 30, 2015 | -0.13 |
| Jun 30, 2015 | -0.14 |
| Mar 31, 2015 | -0.12 |
| Dec 31, 2014 | -0.03 |
| Sep 30, 2014 | -0.11 |
| Jun 30, 2014 | -0.05 |
| Mar 31, 2014 | -0.04 |
| Dec 31, 2013 | -0.07 |
| Sep 30, 2013 | -0.12 |
| Jun 30, 2013 | -0.08 |
| Mar 31, 2013 | -0.09 |
| Dec 31, 2012 | -0.15 |
| Sep 30, 2012 | -0.10 |
| Jun 30, 2012 | -0.02 |
| Mar 31, 2012 | -0.12 |
| Dec 31, 2011 | -0.13 |
| Sep 30, 2011 | -0.10 |
| Jun 30, 2011 | -0.06 |
| Mar 31, 2011 | -0.06 |
| Dec 31, 2010 | -0.06 |
| Sep 30, 2010 | -0.05 |
| Jun 30, 2010 | -0.03 |
| Mar 31, 2010 | -0.08 |
| Dec 31, 2009 | -0.07 |
| Sep 30, 2009 | -0.06 |
| Jun 30, 2009 | 0.08 |
| Mar 31, 2009 | -0.08 |